Sotagliflozin effective in treating patients with type 1 diabetes.
Lisa Neuman
Advertisement
Articles by Lisa Neuman
Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.
Patients who switched to insulin glargine were 57% less likely to experience hypoglycemia.
Lennox-Gastaut syndrome is a severe form of epilepsy that begins in childhood.
Advertisement
Latest Updated Articles
Cannabidiol May Reduce Seizures in Lennox-Gastaut SyndromePublished: April 24th 2017 | Updated:
Study Shows Switching to Toujeo Lowers Risk of Hypoglycemia in Seniors With DiabetesPublished: June 11th 2017 | Updated:
Soliqua Shows Promise Lowering Hemoglobin A1C Levels in Type 2 DiabetesPublished: June 12th 2017 | Updated:
Findings from inTandem1 and inTandem2 Featured at ADA Scientific SessionsPublished: June 12th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
2
The Unit-Based Pharmacist: Roles, Responsibilities, and Real Impact
3
Navigating the New Standard of Care: Patient Needs and the Pharmacist’s Critical Role in Perioperative MIBC Treatment
4
RSV Vaccination as a Public Health Priority: Protecting Communities Through Pharmacy Access
5
